ProCE Banner Activity

Clinical Impact of New Data From HIVR4P 2021 Virtual

Slideset Download
Conference Coverage
In this downloadable slideset, CCO’s expert faculty members summarize key studies from this important conference, including clinical data on new PrEP options, implementation strategies, multipurpose prevention technologies, and an emerging treatment.

Released: February 17, 2021

Expiration: February 16, 2022

No longer available for credit.

Share

Faculty

Linda-Gail Bekker

Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD

CEO, Desmond Tutu Health Foundation
Director, Desmond Tutu HIV Centre
Professor of Medicine
Faculty of Health Sciences
University of Cape Town
Cape Town, South Africa

Kenneth Mayer

Kenneth Mayer, MD

Infectious Disease Attending
Beth Israel Deaconess Medical Center
Professor of Medicine
Harvard Medical School
Medical Research Director
Fenway Community Health
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

ViiV Healthcare

Partners

IAS 2018

ProCE Banner

IAS 2021 HIV R4P

ProCE Banner

Faculty Disclosure

Primary Author

Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD

CEO, Desmond Tutu Health Foundation
Director, Desmond Tutu HIV Centre
Professor of Medicine
Faculty of Health Sciences
University of Cape Town
Cape Town, South Africa

Kenneth Mayer, MD

Infectious Disease Attending
Beth Israel Deaconess Medical Center
Professor of Medicine
Harvard Medical School
Medical Research Director
Fenway Community Health
Boston, Massachusetts